Australia - englanti - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - carvedilol -

Yhdysvallat - englanti - NLM (National Library of Medicine)

blenheim pharmacal, inc. - carvedilol (unii: 0k47ul67f2) (carvedilol - unii:0k47ul67f2) - carvedilol 3.125 mg - carvedilol tablets, usp are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤40% (with or without symptomatic heart failure) [see clinical studies (14.2) ]. carvedilol tablets, usp is indicated for the management of essential hypertension [see clinical studies (14.3) ]. it can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics [see drug interactions (7.2) ]. carvedilol is contraindicated in the following conditions: pregnancy category c. studies performed in pregnant rats and rabbits given carvedilol revealed increased post-implantation loss in rats at doses of 300 mg/kg/day (50 times the maximum recommended human dose [mrhd] as mg/m2 ) and in rabbits at doses of 75 mg/kg/day (25 times the mrhd as mg/m2 ). in the rats, there was also a decrease in fetal body weight at the maternally toxic dose of 300 mg/kg/day (50 times the

Portugali - portugali - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - carvedilol - comprimido revestido por película - 25 mg - carvedilol 25 mg - carvedilol - genérico - duração do tratamento: longa duração

Portugali - portugali - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - carvedilol - comprimido revestido por película - 6.25 mg - carvedilol 6.25 mg - carvedilol - genérico - duração do tratamento: longa duração

Portugali - portugali - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - carvedilol - comprimido revestido por película - 25 mg - carvedilol 25 mg - carvedilol - genérico - duração do tratamento: longa duração

Portugali - portugali - INFARMED (Autoridade Nacional do Medicamento e Produtos de Saúde)

generis farmacêutica, s.a. - carvedilol - comprimido revestido por película - 6.25 mg - carvedilol 6.25 mg - carvedilol - genérico - duração do tratamento: longa duração

Australia - englanti - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - carvedilol, quantity: 6.25 mg - tablet, film coated - excipient ingredients: povidone; colloidal anhydrous silica; lactose monohydrate; magnesium stearate; polysorbate 80; titanium dioxide; macrogol 400; hypromellose; crospovidone; sucrose - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - englanti - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - carvedilol, quantity: 3.125 mg - tablet, film coated - excipient ingredients: hypromellose; macrogol 400; crospovidone; povidone; lactose monohydrate; magnesium stearate; titanium dioxide; colloidal anhydrous silica; polysorbate 80; sucrose - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - englanti - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - carvedilol, quantity: 25 mg - tablet, film coated - excipient ingredients: polysorbate 80; povidone; macrogol 400; magnesium stearate; hypromellose; colloidal anhydrous silica; crospovidone; sucrose; lactose monohydrate; titanium dioxide - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - englanti - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - carvedilol, quantity: 12.5 mg - tablet, film coated - excipient ingredients: sucrose; colloidal anhydrous silica; crospovidone; magnesium stearate; povidone; polysorbate 80; hypromellose; lactose monohydrate; macrogol 400; titanium dioxide - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).